Cargando…
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
The biggest challenge in the field of gene therapy is how to effectively deliver target genes to special cells. This study aimed to develop a new type of poly(D,L-lactide-co-glycolide) (PLGA)-based nanoparticles for gene delivery, which are capable of overcoming the disadvantages of polyethylenimine...
Autores principales: | Liang, Gao Feng, Zhu, Yan Liang, Sun, Bo, Hu, Fei Hu, Tian, Tian, Li, Shu Chun, Xiao, Zhong Dang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211866/ https://www.ncbi.nlm.nih.gov/pubmed/21749688 http://dx.doi.org/10.1186/1556-276X-6-447 |
Ejemplares similares
-
Silver Nanoparticles Induce HePG-2 Cells Apoptosis Through ROS-Mediated Signaling Pathways
por: Zhu, Bing, et al.
Publicado: (2016) -
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010) -
In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters
por: Hu, Yun, et al.
Publicado: (2014) -
Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery
por: Wu, Zhi Min, et al.
Publicado: (2012) -
Devising Hyperthermia Dose of NIR-Irradiated Cs(0.33)WO(3) Nanoparticles for HepG2 Hepatic Cancer Cells
por: Hu, Po-Sheng, et al.
Publicado: (2021)